SCHEMBL3049009

SCHEMBL3049009

COC(=O)c1cc(C)ccc1NC(=O)c1cccc(Cl)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 2/20 0.61
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
ALDH1A1 P00352 4/20 0.60
KDM4E B2RXH2 3/20 0.60
GAA P10253 1/20 0.60
KCNK3 O14649 1/20 0.56
KCNK9 Q9NPC2 1/20 0.56
MAPT P10636 2/20 0.55
POLB P06746 1/20 0.54
TP53 P04637 1/20 0.54
LMNA P02545 1/20 0.53
KCNMA1 Q12791 1/20 0.52
GRM5 P41594 1/20 0.52
AKR1C4 P17516 1/20 0.51
AKR1C3 P42330 1/20 0.51
AKR1C2 P52895 1/20 0.51
AKR1C1 Q04828 1/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2878827 0.85 KDM4E (0.61) GFERMEN1KMT2AALDH1A1KDM4E
SCHEMBL421465 0.84 SERPINE1 (0.65) GFERMEN1KMT2AALDH1A1KDM4E
SCHEMBL3050158 0.83 POLB (0.56) GFERMEN1KMT2AALDH1A1KDM4E
SCHEMBL418492 0.82 AKR1C4 (0.57) GFERMEN1KMT2AALDH1A1KDM4E
SCHEMBL418984 0.81 GRIK1 (0.64) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL420185 0.80 SERPINE1 (0.77) ALDH1A1KDM4EMAPTAKR1C4AKR1C3
SCHEMBL267931 0.79 HPGD (0.57) GFERMEN1KMT2AALDH1A1KDM4E
SCHEMBL6720902 0.76 MEN1 (1.00) GFERMEN1KMT2AALDH1A1MAPT
SCHEMBL417914 0.76 SERPINE1 (0.64) MAPTAKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL418400 0.76 SERPINE1 (0.60) KMT2AALDH1A1KDM4EGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110294853-A1 Bis Aromatic Compounds for Use in the Treatment of Inflammation BIOLIPOX AB (SE) 2011-12-01 US disclosed
WO-2010029300-A1 BIS AROMATIC COMPOUNDS FOR USE IN THE TREATMENT OF INFLAMMATION BIOLIPOX AB (SE) 2010-03-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294853-A1 Bis Aromatic Compounds for Use in the Treatment of Inflammation LTC4S, LTB4R2, LTB4R GFER 1283/4885MEN1 4133/4885KMT2A 3724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.